Opening of Bids - Demolition of Rabbi Shulman Apartments Proj No 125-014 - Pitsch Companies

Home Browse Search

• be further evaluated by the Company's SAP to determine the employee's compliance with any education/treatment program prescribed by the SAP; and • pass a DOT return -to -duty drug and/or alcohol test. f. follow --up [Ref 382.311, 382.605(c)(2)(H), 40.67(b)]. Employer must require following the "directly observed specimen collection" procedures in 40.67. The Company is not required to reinstate or rehire an employee who violates any DOT regulation or any Company policy concerning drugs and alcohol, and by the inclusion of this provision does not obligate itself to do so. ii. Should the Company elect to reinstate or rehire such employee, s/he • must remain in full compliance with the provisions of a above; • must meet all other requirements of the position; and • will be subject to a minimum of 6 (or more, as determined by the SAP) unannounced follow- up tests over the 12 months after returning to duty. iii. At the direction of the SAP, the employee may be required to submit to further unannounced testing for up to four additional years. B-6 TESTING PROCEDURES GENERAL. To protect employees, the integrity of testing processes, and to ensure the validity of the test results, DOT has established stringent regulations to which the Company and its service agents will adhere. DOT's requirements include procedures covering: specimen collection processes; chain -of -custody for specimens; initial and confirmation tests; review of positive test results by a Medical Review Officer (MRO); reporting and recordkeeping. All agreements and arrangements, written or unwritten, between and among employers and service agents concerning the implementation of DOT agency drug and alcohol testing requirements are deemed, as a matter of law, to require compliance with all applicable provisions of 49 CFR Part 40 and FMCSA drug and alcohol testing regulations (see Section 5 for DOT agency regulations). Compliance with the regulations is a material term of all such agreements. A service agent who violates these regulations is subject to a Public Interest Exclusion (PIE) by FMCSA. The company is prohibited from using the services of a service agent who is subject to a PIE in accordance with 49 CFR part 40, subpart R. The PIE list is updated at: http://dot.goy/ost/dapc. a. specimen collection and chain -of -custody [Ref 40.31-73, 40.171-2771 General: For both alcohol and drug testing, specimen donors must report for testing immediately following notification. A DOT required Custody and Control Form (CCF) and/or Alcohol Testing Form (ATF) will be utilized. Specimen donors will receive a copy of the applicable CCF/ATF at the time specimens are to be provided. See Appendix C for additional information about specimen collection. The Collection Site Person (CSP), Breath Alcohol Technician (BAT) or Screening Test Technician (STT) respectively, is responsible for maintaining the integrity of the specimen collection and transfer process, ensuring the modesty and privacy of the specimen donor, and avoiding any conduct or remarks that might be construed as accusatorial or otherwise offensive or inappropriate. The collection site must provide for visual and aural privacy during the collection. The employee's direct supervisor is not permitted to serve as the urine specimen collector for a drug test unless it is impracticable for another individual to perform this function. In addition, specimen collection sites are required to implement a policy and procedures to prevent unauthorized personnel from entering any part of the site in which urine specimens are collected or stored. Only employees being tested, collectors/STTs/BATs and other collection or testing site workers, DERs, employee and employer representatives authorized by the DER or other company official, and DOT agency representatives are authorized access to respective drug or 2020 Drug Screens Plus. All Rights Reserved. (14) FMCSA 20200101 266